Carlsbad, CA, United States of America

Dieter A Kubli

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ionis Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dieter A Kubli. Retrieved from https://idiyas.com/inventor/dieter-a-kubli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dieter A. Kubli: Innovator in Reducing PLN Expression

Introduction

Dieter A. Kubli is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of biotechnology, particularly in the development of methods for reducing PLN expression. His work is crucial for advancing therapeutic strategies in various medical conditions.

Latest Patents

Dieter holds a patent titled "Compounds and Methods for Reducing PLN Expression." This patent represents his innovative approach to addressing challenges in the medical field. He has 1 patent to his name, showcasing his commitment to research and development.

Career Highlights

Dieter A. Kubli is currently employed at Ionis Pharmaceuticals, Inc. His role at this leading biotechnology company allows him to work on cutting-edge research and contribute to the development of novel therapies. His expertise and dedication have made him a valuable asset to the organization.

Collaborations

Dieter has collaborated with several talented individuals in his field, including Brooke A. Anderson and Eric E. Swayze. These collaborations have fostered a productive environment for innovation and have led to advancements in their shared research interests.

Conclusion

Dieter A. Kubli is a prominent figure in the biotechnology sector, with a focus on reducing PLN expression. His patent and work at Ionis Pharmaceuticals, Inc. highlight his contributions to medical research. His collaborations further enhance the impact of his innovative efforts in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…